Hereditary Hemorrhagic Telangiectasia (HHT) Center

Health Resources and Services Administration · HHS

CFDA Numbers

93.110

Award Ceiling

$2.9M

Award Floor

—

Expected Awards

Close Date

Jun 15, 2026

Section I

How to Apply

View on grants_gov ↗

Program Contact

nwilliams1@hrsa.gov
240-475-3310

Section II

Eligibility

"Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.

Eligible Applicant Types

00, 99

Section III

Description

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.

Section IV

Key Dates

Posted: May 15, 2026
Closes: Jun 15, 2026
Archive: Jul 15, 2026